In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...
Health and pharmaceutical stocks — including Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX), Novavax ... Is NVAX stock a sell in December 2024? Novavax, Inc. (Nasdaq: NVAX), a global company ...
Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...
Autolus Therapeutics' obe-cel, branded Aucatzyl, is the first CAR-T therapy approved without a REMS, highlighting its safety and unique mechanism.
Investors, analysts and the interested public are invited to join the event MAINZ, Germany, October 21, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company ...
Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock ...
Gentex (NASDAQ:GNTX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at B. Riley in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results